Clinical Trials Directory

Trials / Completed

CompletedNCT00004769

Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic Dystrophy

Myotonic Dystrophy:Muscle Wasting and Altered Metabolism

Status
Completed
Phase
Study type
Observational
Enrollment
130 (actual)
Sponsor
University of Rochester · Academic / Other
Sex
All
Age
21 Years – 60 Years
Healthy volunteers
Accepted

Summary

OBJECTIVES: I. Examine the interrelationships between muscle wasting (phenotype), the degree of myotonic dystrophy (DM) gene expression (genotype) in patients with DM. II. Characterize the insulin resistance in these patients. III. Assess the glucose uptake in the leg and forearm tissues of these patients. IV. Determine the stability of the DM gene lesion in muscles over a 5-10 year period.

Detailed description

PROTOCOL OUTLINE: Patients are placed on a meatless diet 3 days prior to study entry. During the first 5-day hospital stay, patients receive an oral glucose tolerance test, an intravenous glucose tolerance test, and an intravenous infusion of insulin and glucose (dextrose) to determine the degree of insulin resistance. Patients also receive dual x-ray absorptiometry (DEXA) scan and total body potassium count to measure muscle mass. Patients undergo strength testing and physical fitness screening. A needle biopsy is performed to investigate the genetic alterations associated with this disease. During the second 3-day hospital stay, patients receive an intravenous infusion of insulin, stable isotopic glucose, and stable isotopic glycerol. During the third 3-day hospital stay, a catheter is placed in the femoral artery, femoral vein, and in each arm. Patients receive an infusion of stable isotopic glucose, stable isotopic phenylalanine, and insulin. Measurements of the balance of amino acids and glucose across the forearm and leg are completed. Green dye is infused to measure blood flow in the leg.

Conditions

Timeline

Start date
1993-12-01
Primary completion
2000-03-01
Completion
2000-03-01
First posted
2000-02-25
Last updated
2013-01-28

Source: ClinicalTrials.gov record NCT00004769. Inclusion in this directory is not an endorsement.